Moteur de recherche d’entreprises européennes

Société mère directe Ler 31/07/2023 Global Legal Entity Identifier Foundation (Relationships)

Vue d’ensemble

Texte

Relationship Record Details

This record describes a relationship between two entities identified by their Legal Entity Identifiers (LEIs).

Relationship Information

Field Value
Relationship Type IS_DIRECTLY_CONSOLIDATED_BY
Start Node LEI 549300BBV8QORU8WX093
End Node LEI 54930086XQKV1JUFNE19
Relationship Status ACTIVE

Relationship Periods

This section details the timeframes during which the relationship was active or relevant.

Period Type Start Date End Date
ACCOUNTING_PERIOD 2021-01-01T00:00:00Z 2021-12-31T00:00:00Z
RELATIONSHIP_PERIOD 2019-06-18T00:00:00Z -

Relationship Qualifiers

Qualifier Dimension
ACCOUNTING_STANDARD

Registration Information

This section provides details about the registration of this relationship record.

Field Value
Initial Registration Date 2014-02-07T01:13:00Z
Last Update Date 2023-07-31T17:11:36.903Z
Registration Status LAPSED
Next Renewal Date 2023-06-08T12:10:00Z
Managing LOU 213800WAVVOPS85N2205
Validation Sources ENTITY_SUPPLIED_ONLY
Validation Documents SUPPORTING_DOCUMENTS

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Glaxosmithkline Intellectual Property (NO.2) Ltd., Stevenage, Royaume Uni.